References
- Appelbaum PC, Jacobs SK, Spangler SK, Yamabe S. Comparative activity of β-lactamase inhibitors YTR-830, clavulanate and sulbactam combined with β-lactams against β-lactamase-producing anerobes. Antimicrob Agents Chemother 1986; 30: 789–791.
- Neu HC, Fu KP. Clavulanic acid, a novel inhibitor of β-lactamases. Antimicrob Agents Chemother 1978; 14: 650–655.
- Wexler HM, Harris B, Carter WT, Finegold SM. In vitro efficacy of sulbactam combined with ampicillin against anaerobic bacteria. Antimicrob Agents Chemother 1985; 27: 876–878.
- Finegold SM. Abdominal and perineal infections. In: Finegold, SM ed. Anaerobic Bacteria in Human Disease. New York: Academic Press, 1977: 257–313.
- Gorbach SL, Bartlett JG. Anaerobic infections. N Engl J Med 1974; 290: 1117–1184.
- Gorbach SL, Bartlett JG. Anaerobic infections. N Engl J Med 1974; 290: 1237–1245.
- Gorbach SL & Bartlett JG. Anaerobic infections. N Engl J Med 1974; 290: 1289–1294.
- Wexler HM, Finegold SM. Antimicrobial resistance in Bacteroides. J Antimicrob Chemother 1987; 19: 143–146.
- Sutter VL. Susceptibility testing of anaerobes. In: Lennette EH, Balows A, Hausler WJ, Shadomy HJ. eds. Manual of Clinical Microbiology. Washington: American Society for Microbiology, 1985: 988–990.
- Schoencknecht FD, Sabath LD, Thornsberry C. Susceptibility tests. Special Tests. In: Lennette EH, Balows A, Hausler WJ, Shadomy HJ. eds. Manual of Clinical Microbiology. Washington: American Society for Microbiology, 1985: 1000–1008.
- Kroogstad DJ, Moellering RC. Antimicrobial combinations. In: Lorian V. ed. Antibiotics in Laboratory Medicine. Baltimore: Williams & Wilkins, 1986: 537–595.
- Lorian V. Effects of subrninimum inhibitory concentrations of antibiotics in bacteria. In: Lorian V. ed. Antibiotics in Laboratory Medicine. Baltimore: Williams & Wilkins, 1980: 342–408.
- Craig WA, Gudmundsson S. The postantibiotic effect. In: Lorian V. ed. Antibiotics in Laboratory Medicine. Baltimore: Williams & Wilkins, 1986: 515–536.
- Cuchural GJ, Tally FP, Jacobus NV, et al. Antimicrobial susceptibility of 1292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 and 1982. Antimicrob Agents Chemother 1984; 26: 145–148.
- Dubreuil L, Devos J, Neut C, Romond C. Susceptibility of anaerobic bacteria from several French hospitals. Antimicrob Agents Chemother 1984; 25: 764–766.
- García-Rodríguez JA, García Sánchez JE. Evolution of the Bacteroides fragilis group antimicrobial susceptibility in Spain. Chemioterapia 1985; 4 (Suppl. 2): 806–808.
- Phillips I, Warren C, Taylor E, Timewell R, Eykyn S. The antimicrobial susceptibility of anaerobic bacteria in a London teaching hospital. J Antimicrob Chemother 1981; 8 (suppl. D): 17–26.
- Reig M, Campello MG, Baquero F. Epidemiology of clindamycin resistance in the Bacteroides fragilis group. J Antimicrob Chemother 1984: 14: 595–603.
- Tally FP, Cuchural GJ, Jacobus NV et al. Nationwide study of the susceptibility of the Bacteroides fragilis group in the United States. Antimicrob Agents Chemother 1985; 28: 675–677.
- Piddock LJV, Wise R. Cefoxitin resistance in Bacteroides species: evidence indicating two mechanisms causing decreased susceptibility. J Antimicrob Chemother 1987, 19: 161–170.
- Cuchural GJ, Tally FP, Jacobus NV, Marsh PK, Mayhew JW. Cefoxitin inactivation by Bacteroides fragilis. Anti-microb Agents Chemother 1983; 24: 936–940.
- Yotsuji A, Minami S, Inoue M, Mitsuhashi, S. Properties of novel β-lactamases produced by Bacteroides fragilis. Antimicrob Agents Chemoter 1983; 24: 925–929.
- Jones RN, Barry AL. In vitro activity ampicillin/sulbactam against cefoxitin-resistant anaerobic bacteria. J Antimicrob Chemother 1988; 21: 135–138.
- Vogelman B, Craig WA. Kinetics of antimicrobial activity. J Pediatr 1986; 108: 835–840.
- Bustamante CI, Drusano GL, Tatem BA, Standford HC. Postantibiotic effect in Pseudomonas aeruginosa. Anti-microb Agents Chemother 1984; 26: 678–683.
- Werk R, Schneider L. Response of Streptococci to subinhibitory and inhibitory concentrations of ciprofloxacin. Rev Infect Dis 1988; 10 (Suppl. 1): 23–24.